La chaîne d'options affiche les données clés des options sur actions de Upstream Bio à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Upstream Bio..

Upstream Bio (NASDAQ:UPB) Stock, Chaîne d'Options

Upstream Bio

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.

Upstream Bio Inc

Upbound Group Inc

UNITED PLANT BERHAD ORD by United Plantations Berhad

United Plantation Bhd

UpBots

News

Press Releases

Upstream Bio to Present at Upcoming March Investor Conferences

Earnings

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

Management

Upstream Bio Appoints Stacy Price as Chief Technology Officer

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Health Care

Upstream Bio to Present Mechanistic Insights into Verekitug's Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)

Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies

Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress

BBNX

BCAX

IMGO

KMTS

MORF

Akebia Therapeutics

ArriVent BioPharma

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Geron

Immunome

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

MiMedx Group

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Nurix Therapeutics

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Precigen

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

uniQure

Sana Biotechnology

Sionna Therapeutics

Stoke Therapeutics

Spyre Therapeutics

Tango Therapeutics

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

UroGen Pharma

Valneva

Zymeworks

JP Morgan

Piper Sandler

Comments

Upstream Bio

Upstream Bio (UPB) Options

Upstream Bio (NASDAQ:UPB) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL